Inhibrx Biosciences, Inc. · NASDAQ:INBX
BlackRock, Inc. reported a 5.70% stake in Inhibrx Biosciences, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc. reported a 5.70% stake in Inhibrx Biosciences, Inc., 831,807 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 831,807
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.70% | 831,807 |
Source
Related
- Inhibrx Biosciences, Inc.
- BlackRock, Inc.
- Inhibrx Biosciences, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Lappe Mark · Oct 14, 2026
- Form 4 · Lappe Mark · Sep 28, 2026
- Form 4 · Kayyem Jon Faiz · Sep 23, 2026
- Form 4 · Kayyem Jon Faiz · Sep 17, 2026
- Form 4 · Manhard Kimberly · Sep 15, 2026